Revance Therapeutics
RVNC
#7256
Rank
C$0.54 B
Marketcap
$5.25
Share price
0.00%
Change (1 day)
-35.28%
Change (1 year)

Market capitalization of Revance Therapeutics (RVNC)

Market cap: C$0.54 Billion

As of March 2025 Revance Therapeutics has a market cap of C$0.54 Billion. This makes Revance Therapeutics the world's 7256th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Revance Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025C$0.54 B19.48%
2024C$0.45 B-55.23%
2023C$1.02 B-50.32%
2022C$2.06 B38.01%
2021C$1.49 B-37.91%
2020C$2.40 B116.61%
2019C$1.11 B9.5%
2018C$1.01 B-37.96%
2017C$1.63 B106.03%
2016C$0.79 B-40.83%
2015C$1.34 B186.82%
2014C$0.46 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$0.10 B-80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
C$563.94 B 102,872.04%๐Ÿ‡บ๐Ÿ‡ธ USA
C$29.33 B 5,256.76%๐Ÿ‡บ๐Ÿ‡ธ USA